Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001487371-19-000188
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-08-19 17:15:22
Reporting Period:
2019-08-15
Accepted Time:
2019-08-19 17:15:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1487371 Genmark Diagnostics Inc. GNMK () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203567 C Kevin Oboyle 5964 La Place Court
Carlsbad CA 92008
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-08-15 2,200 $6.51 102,112 No 4 S Direct
Common Stock Disposition 2019-08-16 16,150 $6.51 85,962 No 4 S Direct
Common Stock Acquisiton 2019-08-15 25,000 $6.00 110,962 No 4 M Direct
Common Stock Acquisiton 2019-08-15 18,050 $6.00 129,012 No 4 M Direct
Common Stock Disposition 2019-08-15 23,365 $6.42 105,647 No 4 F Direct
Common Stock Disposition 2019-08-15 16,870 $6.42 88,777 No 4 F Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-08-15 25,000 $0.00 25,000 $6.00
Common Stock Stock Option (Right to Buy) Disposition 2019-08-15 18,050 $0.00 18,050 $6.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-05-28 No 4 M Direct
0 2020-05-28 No 4 M Direct
Footnotes
  1. The shares were sold pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person in June 2019.
  2. The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $6.50 to $6.53. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
  3. The price reported is the weighted average price per share. Shares were sold in multiple transactions at prices ranging from $6.50 to $6.54. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price.
  4. The Reporting Person was issued 1,635 shares of the Company's common stock pursuant to the net exercise of the designated stock options. As a result, the Company withheld 23,365 shares of common stock underlying the exercised stock options for the payment of the exercise price using the closing stock price on August 15, 2019 of $6.42 per share, pursuant to the terms of the Company's 2010 Equity Incentive Plan.
  5. The Reporting Person was issued 1,180 shares of the Company's common stock pursuant to the net exercise of designated stock options. As a result, the Company withheld 16,870 shares of common stock underlying the exercised stock option for the payment of the exercise price using the closing stock price on August 15, 2019 of $6.42 per share, pursuant to the terms of the Company's 2010 Equity Incentive Plan.